Advanced search
1 file | 882.23 KB Add to list

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial

Piet Ost (UGent) , Dries Reynders (UGent) , Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , Nicolaas Lumen (UGent) , Aurélie De Bruycker (UGent) , Bieke Lambert (UGent) , Louke Delrue (UGent) , Renée Bultijnck (UGent) , Tom Claeys, et al.
(2018) JOURNAL OF CLINICAL ONCOLOGY. 36(5). p.446-453
Author
Organization
Keywords
POSITRON-EMISSION-TOMOGRAPHY, QUALITY-OF-LIFE, CURATIVE TREATMENT, CLINICAL-TRIALS, DISEASE, RECOMMENDATIONS, RADIOTHERAPY, GUIDELINES, SURVIVAL, QLQ-C30

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 882.23 KB

Citation

Please use this url to cite or link to this publication:

MLA
Ost, Piet, et al. “Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence : A Prospective, Randomized, Multicenter Phase II Trial.” JOURNAL OF CLINICAL ONCOLOGY, vol. 36, no. 5, 2018, pp. 446–53, doi:10.1200/JCO.2017.75.4853.
APA
Ost, P., Reynders, D., Decaestecker, K., Fonteyne, V., Lumen, N., De Bruycker, A., … De Meerleer, G. (2018). Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial. JOURNAL OF CLINICAL ONCOLOGY, 36(5), 446–453. https://doi.org/10.1200/JCO.2017.75.4853
Chicago author-date
Ost, Piet, Dries Reynders, Karel Decaestecker, Valerie Fonteyne, Nicolaas Lumen, Aurélie De Bruycker, Bieke Lambert, et al. 2018. “Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence : A Prospective, Randomized, Multicenter Phase II Trial.” JOURNAL OF CLINICAL ONCOLOGY 36 (5): 446–53. https://doi.org/10.1200/JCO.2017.75.4853.
Chicago author-date (all authors)
Ost, Piet, Dries Reynders, Karel Decaestecker, Valerie Fonteyne, Nicolaas Lumen, Aurélie De Bruycker, Bieke Lambert, Louke Delrue, Renée Bultijnck, Tom Claeys, Els Goetghebeur, Geert Villeirs, Kathia De Man, Filip Ameye, Ignace Billiet, Steven Joniau, Friedl Vanhaverbeke, and Gert De Meerleer. 2018. “Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence : A Prospective, Randomized, Multicenter Phase II Trial.” JOURNAL OF CLINICAL ONCOLOGY 36 (5): 446–453. doi:10.1200/JCO.2017.75.4853.
Vancouver
1.
Ost P, Reynders D, Decaestecker K, Fonteyne V, Lumen N, De Bruycker A, et al. Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial. JOURNAL OF CLINICAL ONCOLOGY. 2018;36(5):446–53.
IEEE
[1]
P. Ost et al., “Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial,” JOURNAL OF CLINICAL ONCOLOGY, vol. 36, no. 5, pp. 446–453, 2018.
@article{8545939,
  author       = {{Ost, Piet and Reynders, Dries and Decaestecker, Karel and Fonteyne, Valerie and Lumen, Nicolaas and De Bruycker, Aurélie and Lambert, Bieke and Delrue, Louke and Bultijnck, Renée and Claeys, Tom and Goetghebeur, Els and Villeirs, Geert and De Man, Kathia and Ameye, Filip and Billiet, Ignace and Joniau, Steven and Vanhaverbeke, Friedl and De Meerleer, Gert}},
  issn         = {{0732-183X}},
  journal      = {{JOURNAL OF CLINICAL ONCOLOGY}},
  keywords     = {{POSITRON-EMISSION-TOMOGRAPHY,QUALITY-OF-LIFE,CURATIVE TREATMENT,CLINICAL-TRIALS,DISEASE,RECOMMENDATIONS,RADIOTHERAPY,GUIDELINES,SURVIVAL,QLQ-C30}},
  language     = {{eng}},
  number       = {{5}},
  pages        = {{446--453}},
  title        = {{Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial}},
  url          = {{http://doi.org/10.1200/JCO.2017.75.4853}},
  volume       = {{36}},
  year         = {{2018}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: